Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for iBio (IBIO) over the last 9 years, with Q4 2025 value amounting to $597000.0.

  • iBio's Long-Term Debt Repayments rose 102641.51% to $597000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $771000.0, marking a year-over-year decrease of 3471.63%. This contributed to the annual value of $218000.0 for FY2025, which is 8559.15% down from last year.
  • iBio's Long-Term Debt Repayments amounted to $597000.0 in Q4 2025, which was up 102641.51% from $60000.0 recorded in Q3 2025.
  • In the past 5 years, iBio's Long-Term Debt Repayments registered a high of $6.2 million during Q4 2022, and its lowest value of $51000.0 during Q3 2024.
  • In the last 4 years, iBio's Long-Term Debt Repayments had a median value of $436000.0 in 2023 and averaged $1.1 million.
  • Within the past 5 years, the most significant YoY rise in iBio's Long-Term Debt Repayments was 102641.51% (2025), while the steepest drop was 9461.47% (2025).
  • Quarter analysis of 4 years shows iBio's Long-Term Debt Repayments stood at $6.2 million in 2022, then plummeted by 93.02% to $436000.0 in 2023, then plummeted by 87.84% to $53000.0 in 2024, then surged by 1026.42% to $597000.0 in 2025.
  • Its last three reported values are $597000.0 in Q4 2025, $60000.0 for Q3 2025, and $58000.0 during Q2 2025.